
Topic
Prior Authorization
Documentation, step edits, renewal cycles, appeals, and how payer criteria shape real-world drug use.

Pricing & Access· May 27, 2026 · 10 min read

Pricing & Access· May 27, 2026 · 12 min read
Trikafta and Alyftrek CFTR modulator access guide

Pricing & Access· May 27, 2026 · 9 min read
Trodelvy access guide for breast cancer coverage
By Ran Chen#Oncology#ADC#Prior Authorization

Pricing & Access· May 27, 2026 · 12 min read
Tysabri and Tyruko natalizumab biosimilar access guide

Pricing & Access· May 27, 2026 · 10 min read
Vabysmo coverage guide for retina access

Pricing & Access· May 27, 2026 · 15 min read
Vyvgart vs Vyvgart Hytrulo access guide

Biosimilars· May 27, 2026 · 11 min read
Xolair and Omlyclo omalizumab access guide

Pricing & Access· May 27, 2026 · 12 min read
Yescarta vs Tecartus CAR-T access guide
By Ran Chen#Oncology#CAR-T#Prior Authorization

Approvals· May 26, 2026 · 8 min read
Novel FDA drug approvals Q1-Q2 2026: the fifteen drugs and their formulary implications
By Ran Chen#FDA Approval#Novel Drug Approvals#GLP-1

Pricing & Access· May 26, 2026 · 7 min read
Veppanu coverage guide for ER+/HER2- breast cancer
By Ran Chen#PROTAC#Breast Cancer#Companion Diagnostic